New Brunswick Covers Lucentis Treatments for Wet Macular Degeneration

Lucentis, the leading treatment for the eye disease wet macular degeneration is now covered through the New Brunswick Prescription Drug Plan (NBPDP).  The November 16 announcement ensures that people … [Read more...]

Eye Drops for Dry Macular Degeneration?

A topical eye drop treatment for dry macular degeneration may be one step closer to reality after MacuCLEAR's drug MC-1101 and Mystic Pharmaceuticals VersiDoser phase 1b clinical trial showed … [Read more...]

Avastin as Effective as Lucentis for Macular Degeneration

Avastin as effective as Lucentis for treating macular degeneration.  Researchers have shown that there is no difference between Avastin and Lucentis when used to treat macular … [Read more...]

New Macular Degeneration Treatment on the Horizon?

With researchers at the University of Wisconsin demonstrating they can grow retinal cells from skin cells, a new treatment for macular degeneration may be on the horizong. Macular degeneration is … [Read more...]

Avastin Drug Resistance for Macular Degeneration Patients?

In a new study, researchers have described an apparent desensitization to Avastin in patients undergoing treatments for macular degeneration. This has led to concerns of an increased resistance being … [Read more...]